Skip to main content

Table 4 Outcomes and clinical variables between the groups.

From: Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?

Item All (N = 292) PLR ≤ 0.55 (n = 89) PLR > 0.55 (n = 203) P value+ NLR ≤ 3.92 (n = 226) NLR > 3.92 (n = 66) P value+
LOS in the hospital (days, mean ± SD) 16.0 ± 11.9 18.3 ± 12.9 15.0 ± 11.4 0.018* 15.5 ± 12.0 17.8 ± 11.7 0.027*
LOS in the ICU (days, mean ± SD) 6.3 ± 9.5 8.6 ± 10.9 5.4 ± 8.7 0.002* 5.9 ± 9.6 7.7 ± 9.1 0.062
Anastomotic leaks [n(%)] 36 (12.3) 18 (20.2) 18 (8.9) 0.006* 24 (10.6) 12 (18.2) 0.101
Complications     0.008*    0.671
 None [n(%)] 266 (91.1) 75 (84.3) 191 (94.1)   207 (91.6) 59 (89.4)  
 Cardiac [n(%)] 10 (3.4) 6 (6.7) 4 (2.0) 5 (2.2) 5 (7.6)  
 Respiratory [n(%)] 9 (3.1) 6 (6.7) 3 (1.5) 7 (3.1) 2 (3.0)  
 Infectious [n(%)] 2 (0.7) 0 2 (1.0) 2 (0.9) 0  
 Renal [n(%)] 5 (1.7) 2 (2.2) 3 (1.5) 5 (2.2) 0  
Clavien-Dindo grade ≥ 3[n(%)] 40(13.7) 19 (21.3) 21 (10.3) 0.012* 25 (11.1) 15 (22.7) 0.015*
In-hospital mortality [n(%)] 9 (3.1) 5 (5.6) 4 (2.0) 0.098 2 (0.9) 7 (10.6) < 0.001*
  1. P value+ were calculated for the comparison of groups based on the NLR and PLR values by statistical analysis; +Determined by the Mann-Whitney U test or Spearman’s rho test; *. P value < 0.05; ICU intensive care unit, LOS length of stay, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio